Introduction
CROMSOURCE was contacted by a mid-size biotech company based in the US to conduct a COVID-19 testing study recruiting up to 3,000 patients within a one month period. Due to the timely importance of this study during the pandemic it was imperative that start-up be accelerated and that recruitment began immediately. This would allow us to take advantage of the high positivity rates of COVID-19 in many regions that had not implemented universal guidance documents and/or regulations regarding social distancing and mask wearing.
DownloadFile | Action |
---|---|
CROMSOURCE Case Study - Rapid Start-Up for a US Based Study for COVID-19.pdf | Download |